Cartilage Damage

Also known as: Injury of cartilage / Cartilage injury

DrugDrug NameDrug Description
DB14100Pork CollagenPork Collagen is used within MACIĀ® (autologous cultured chondrocytes on porcine collagen membrane) as an autologous cellularized scaffold product indicated for the repair of single or multiple symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults. It serves as an alternative repair treatment for patients with inadequate response to pre-existing surgical methods. The surgical implantation shows a tolerable safety profile and efficacy up to 4 years, but it is not indicated for patients with osteoarthritis. It has been used since 1995 as Carticel and gained biologic license in 1997. The surgical implantation was first performed in Sweden.
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08818Hyaluronic acid4Not Yet Recruiting1